trial

fMRI of Theory of Mind in Schizophrenia and Bipolar Disorder

NCTId NCT02834182
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Unknown
Enrollment 120 (estimated)
Sponsored by CHU de Reims
Primary completion 2019-06
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
120 (estimated)
Study type
Interventional
Allocation
Non Randomized
Model
Parallel
Masking
None
Start
2016-07
Primary completion
2019-06
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
IRMfMini International Neuropsychiatric InterviewPositive And Negative Syndrom ScaleYoung Mania Rating ScaleHamilton Depression Scale

Sponsors

CHU de ReimsLead Sponsor

Sites

1 total
Reims, France

Facts & assertions

4 sourced
Enrollment
120
Phase
NA
Primary Completion Date
2019-06
Status
UNKNOWN
relationships
The graph out of here
drug
IRMf
drug
Mini International Neuropsychiatric Interview
drug
Positive And Negative Syndrom Scale
drug
Young Mania Rating Scale
drug
Hamilton Depression Scale
drug
lead_sponsor
CHU de Reims
company
indication
Bipolar Disorder, Schizophrenia
indication
Bipolar Disorder
indication
Schizophrenia
indication